Dilept formulation and metabolite exposure in rats
Animal research · 2009
- What was studied
- Rats. The abstract does not provide group sizes.
- Main finding
- Unformulated oral Dilept had less than 1% absolute bioavailability in rats. The tablet improved oral exposure, and two metabolites remained detectable in blood for more than four hours.
Reported findings and study design
HPLC–tandem mass spectrometry of Dilept and metabolites, with structural confirmation by chemical synthesis.
Population or model Rats. The abstract does not provide group sizes.
Dose, route and schedule
Investigators compared oral and intravenous administration and reported an oral tablet dose of 200 mg/kg. The abstract does not specify the other arm doses.
Protocol source ↗ · Original indexed English abstract and pharmacokinetic findings.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Absolute oral bioavailability of unformulated Dilept | Less than 1% | |
| Time detected in plasma after oral treatment | Unchanged drug for at least 30 minutes. Two metabolites for more than 4 hours. |
Source for these results ↗ · Reviewed 2026-11-15
Study limitations and source details
Study limitations
- The abstract describes the tablet’s bioavailability result as a 22% improvement without clearly defining the basis of that percentage. These are formulation-specific rat data.
Source details
Original indexed English abstract and pharmacokinetic findings.
Sources checked
Citation
V. P. Zherdev, S. S. Boiko, N. V. Mesonzhnik, S. A. Appolonova, G. N. Rodchenkov, R. U. Ostrovskaya, T. A. Gudasheva, S. B. Seredenin. Dilept formulation and metabolite exposure in rats Experimental and Clinical Pharmacology. 2009;72(3):16–21.